Back to all Representative Matters
Jun 22, 2020

MediPharm Labs Completes $37.8 Million Private Placement

Melanie Cole, Amy Marcen-Gaudaur, Meredith McCann and Aaron Collins

MediPharm Labs Corp. (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, recently completed a private placement with an institutional investor (the “Investor”) for aggregate gross proceeds of $37,822,500 (the “Offering”).

On June 8, 2020, MediPharm Labs completed the Offering pursuant to which $18,911,250 was related to the placement of a $20.5 million unsecured convertible note and a warrant to purchase up to 3,601,427 common shares of the Company (the “Common Shares”); and $18,911,250 of which is currently being held in escrow and is related to the placement of a subscription receipt entitling the holder to receive, upon satisfaction of certain escrow release conditions, a further $20.5 million unsecured convertible note and a further warrant to purchase up to 3,601,427 Common Shares.

Aird & Berlis LLP represented MediPharm Labs with a team comprised of Melanie Cole, Amy Marcen-Gaudaur and Meredith McCann (capital markets), and Aaron Collins (financial services).

Related Industries

Related Representative Matters

Representative Matters
Energy+ Closes $55 Million Offering of Unsecured Debentures Jill P. Fraser, Melanie Cole and Meredith McCann Aug 10, 2020 On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentu... On August 10, 2020, Energy+ Inc. closed a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060.
Representative Matters
TD Bank Leads $64 Million Syndicated Credit Facilities Jill P. Fraser and Kyle B. Plunkett Oct 23, 2019 Sangoma Technologies Inc. and Sangoma U.S. Inc. entered into a syndicated loan agreement with certain Schedule 1 banks.
Representative Matters
MediPharm Labs Closes $38.7 Million Credit Facility with a Leading Canadian Schedule 1 Bank Aaron Collins and Randy T. Hooke Oct 10, 2019 MediPharm Labs Corp., a global leader in cannabis extraction, distillation, purification and cannabinoid isolation, through its wholly-owned subsidiary, MediPharm Labs Inc., closed a credit facility with a prominent Canadian Schedule 1 bank for an aggregate $38.7 m...